PACTR202009786901147招募中3 期
The Chloroquine/hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomized, placebo-controlled prophylaxis study (COPCOV)
Dr. William Schilling0 个研究点目标入组 1,600 人开始时间: 2020年5月7日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 1,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •18 years and above
- •Participant is willing and able to give informed consent for participation in the study and agrees with the study and its conduct
- •Agrees not to self-medicate with chloroquine, hydroxychloroquine or other potential antivirals (e.g. not on HAART that includes LPV/r as part of the regimen)
- •Not previously diagnosed with COVID-19
- •Not currently symptomatic with an acute respiratory infection (ARI)
- •Possesses an internet-enabled smartphone (Android or iOS) or computer
排除标准
- •Hypersensitivity reaction to hydroxychloroquine or 4-aminoquinolines
- •Contraindication to taking hydroxychloroquine as prophylaxis, e.g. known epileptic, known creatinine clearance < 10 ml/min
- •Already taking chloroquine, hydroxychloroquine or 4-aminoquinolines
- •Taking a concomitant medication described in section 8.5 of the master protocol, which cannot be safely stopped known retinal disease
- •Inability to be followed up for the trial period
- •Known prolonged QT syndrome (ECG will be required for potential participants who report having a heart condition)
- •Is enrolled in another clinical trial (however participants will be allowed to participate in observational studies)
研究者
相似试验
进行中（未招募）
1 期
Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)Profliaxis of SARS-CoV-2 infectionMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862EUCTR2020-001441-39-ITIVERSITY OF OXFORD40,000
进行中（未招募）
1 期
Chloroquine/ hydroxychloroquine prevention of COVID-19 (COPCOV)EUCTR2020-001441-39-GBniversity of Oxford10,000
已完成
3 期
The prophylactic effect of Hydroxychloroquine on Novel Corona virusIRCT20151222025660N2Arak University of Medical Sciences90
尚未招募
不适用
Hydroxychloroquine prophylaxis in Covid 19 infectioCTRI/2020/05/025010Indian council of Medical Research
招募中
2 期
COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD TrialCOVID-19 infectionInfection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12620000501943Walter and Eliza Hall Institute of Medical Research650